🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background Revascularization of a chronic total occlusion (CTO) has gained ...
Status
Completed
Location
Radboudumc
Start Date
2021-12-16
Trial ID
NCT06728384
The purpose of this study is to evaluate the repeatability and reproducibil...
Status
Suspended
Location
London Vision Clinic
Start Date
2022-09-01
Trial ID
NCT03473847
This study aims to evaluate the ability of swept-source optical coherence t...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-21
Trial ID
NCT07690644
According to estimates by the World Health Organization, approximately half...
Status
Recruiting
Location
Shanghai 10th People's Hospital
Start Date
2024-10-01
Trial ID
NCT07424755
Treatments Being Tested
Glaucoma is a chronic and progressive optic neuropathy characterized by deg...
Status
Completed
Location
Ege University Department of Ophthalmology
Start Date
2022-03-01
Trial ID
NCT05253534
Treatments Being Tested
All subjects requiring percutaneous coronary intervention (PCI) and stentin...
Status
Completed
Location
Division of Cardiology, Queen Mary Hospital, The University of Hong Kong
Start Date
2010-10
Trial ID
NCT01274234
Treatments Being Tested
This study was intended to evaluate the efficacy, safety and tolerability o...
Status
Terminated
Location
Research Site
Start Date
2008-06
Trial ID
NCT00624468
Treatments Being Tested
In this observational study, the investigators aim to evaluate whether chan...
Status
Unknown
Location
UZ Leuven
Start Date
2016-03-25
Trial ID
NCT03472482
Treatments Being Tested
This retrospective observational cohort study uses de-identified electronic...
Status
Completed
Location
China Medical University Hospital
Start Date
2015-10-01
Trial ID
NCT07399288
Treatments Being Tested
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested